Search results - 9 results
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.
reflecting waning immunity within this group, which was vaccinated early in 2021 and invited to receive the booster vaccination at that time. In January 2022, a RR increase was observed in all age categories ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
observed high vaccine effectiveness (VE) against SARS-CoV2-infection. The replacement of the alpha-‘variant of concern’ (VOC) by the delta- VOC and uncertainty about the time course of immunity called for ...
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
infection lowered the risk of breakthrough infections and of having symptoms, highlighting the protective effect of hybrid immunity. Health Topics: Effectiveness and safety of vaccines, medicines and health ...
Vaccine-induced and hybrid immunity against the B.1.617.2 and B.1.1.529 variants: a test negative case-control study in Belgium
Publication Type: Scientific poster, presentation or proceeding Authors: Lucy Catteau; Toon Braeye; Pierre Hubin; Matthieu Billuart; Freek Haarhuis; Veerle Stouten; Joris Van Loenhout; Chloé Wyndham-Thomas Source: (2022) Health Topics: Effectiveness and ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
recruited in NH in Belgium before immunization with two doses of 30µg BNT162 b2 mRNA vaccine at day 0 and day 21. Binding antibodies (Ab) to SARS-CoV-2 receptor binding domain (RBD), spike domains S1 and S2, ...
Vaccine quality control in Europe: monitoring the quality of vaccines after licensing
Publication Type: Scientific poster, presentation or proceeding Authors: Lieke Maria van der Aa Source: Immunity for Health, Flanders Vaccine, Issue Flanders Vaccine, Antwerp, Belgium (2020) ...
Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019.
Keywords: Biological Products Drug Development Human Experimentation Humans vaccines whole genome sequencing Abstract: Controlled human infection models can be helpful to study pathogenesis and immune ...
Innate signaling by mycobacterial cell wall components and relevance for development of adjuvants for subunit vaccines.
Adjuvants, Immunologic Animals Antigens, Bacterial Cell Wall Humans Immunity, Innate Lectins, C-Type Models, Animal Mycobacterium Pathogen-Associated Molecular Pattern Molecules Protein Binding Signal ...
Informal consultation with the ad hoc committee on vaccines prequalification for the revision of the procedure for assessing the acceptability, in principle, of vaccines for purchase by UN agencies
Manuscript versions: DOI: https://www.who.int/immunization_standards/vaccine_quality/pq_informal_consultat… File: Version: Published Full text access: Public Access Full text language: English Category: ...